{"title":"成人糖尿病视网膜病变和死亡率:HbA1c作用的因果中介分析","authors":"Zhiyi Wang , Hangshun Guo , Xiaojing Teng","doi":"10.1016/j.diabres.2025.112936","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Diabetic retinopathy (DR) is a well-established risk factor for increased mortality in diabetes, but the mechanisms remain unclear. Chronic hyperglycemia, reflected by glycated hemoglobin (HbA1c), may be one pathway linking DR to adverse outcomes, yet its mediating role is not well defined.</div></div><div><h3>Methods</h3><div>We analyzed data from 5658 adults with self-reported diabetes in the NHANES 2001–2018 cycles. DR was assessed via questionnaire, HbA1c was measured using standardized laboratory methods, and all-cause mortality was determined through linkage to the National Death Index. Cox proportional hazards models were used to assess the association between HbA1c and mortality. Causal mediation analysis was conducted using the mediation R package.</div></div><div><h3>Results</h3><div>Participants with DR had a 34 % higher risk of all-cause mortality compared with those without DR (adjusted HR = 1.34; 95 % CI: 1.20–1.51; <em>P</em> < 0.0001). Higher HbA1c levels were also associated with increased mortality (per 1 % increase: HR = 1.07; 95 % CI: 1.04–1.10; <em>P</em> < 0.0001), and participants in the highest HbA1c tertile had a 30 % greater risk of death than those in the lowest tertile (HR:1.30; 95 %CI:1.14–1.48; <em>P</em> < 0.0001). Mediation analysis indicated that HbA1c accounted for 9.1 % of the excess mortality risk associated with DR, suggesting that DR may elevate mortality risk partly through increased glycemic burden.</div></div><div><h3>Conclusions</h3><div>DR is associated with an increased risk of all-cause mortality, and this excess risk appears to be partly linked through higher HbA1c levels. These findings suggest that elevated glycemic burden may serve as one pathway connecting DR to increased mortality in adults with diabetes.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"229 ","pages":"Article 112936"},"PeriodicalIF":7.4000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diabetic retinopathy and mortality in adults with diabetes: causal mediation analysis of the role of HbA1c\",\"authors\":\"Zhiyi Wang , Hangshun Guo , Xiaojing Teng\",\"doi\":\"10.1016/j.diabres.2025.112936\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Diabetic retinopathy (DR) is a well-established risk factor for increased mortality in diabetes, but the mechanisms remain unclear. Chronic hyperglycemia, reflected by glycated hemoglobin (HbA1c), may be one pathway linking DR to adverse outcomes, yet its mediating role is not well defined.</div></div><div><h3>Methods</h3><div>We analyzed data from 5658 adults with self-reported diabetes in the NHANES 2001–2018 cycles. DR was assessed via questionnaire, HbA1c was measured using standardized laboratory methods, and all-cause mortality was determined through linkage to the National Death Index. Cox proportional hazards models were used to assess the association between HbA1c and mortality. Causal mediation analysis was conducted using the mediation R package.</div></div><div><h3>Results</h3><div>Participants with DR had a 34 % higher risk of all-cause mortality compared with those without DR (adjusted HR = 1.34; 95 % CI: 1.20–1.51; <em>P</em> < 0.0001). Higher HbA1c levels were also associated with increased mortality (per 1 % increase: HR = 1.07; 95 % CI: 1.04–1.10; <em>P</em> < 0.0001), and participants in the highest HbA1c tertile had a 30 % greater risk of death than those in the lowest tertile (HR:1.30; 95 %CI:1.14–1.48; <em>P</em> < 0.0001). Mediation analysis indicated that HbA1c accounted for 9.1 % of the excess mortality risk associated with DR, suggesting that DR may elevate mortality risk partly through increased glycemic burden.</div></div><div><h3>Conclusions</h3><div>DR is associated with an increased risk of all-cause mortality, and this excess risk appears to be partly linked through higher HbA1c levels. These findings suggest that elevated glycemic burden may serve as one pathway connecting DR to increased mortality in adults with diabetes.</div></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":\"229 \",\"pages\":\"Article 112936\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2025-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822725009507\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725009507","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
背景:糖尿病视网膜病变(DR)是糖尿病死亡率增加的一个公认的危险因素,但其机制尚不清楚。由糖化血红蛋白(HbA1c)反映的慢性高血糖可能是将DR与不良后果联系起来的一种途径,但其介导作用尚不明确。方法:我们分析了2001-2018年NHANES周期中5658名自我报告的糖尿病成年人的数据。DR通过问卷评估,HbA1c使用标准化实验室方法测量,全因死亡率通过与国家死亡指数的联系来确定。Cox比例风险模型用于评估HbA1c与死亡率之间的关系。使用中介R包进行因果中介分析。结果DR患者的全因死亡率比无DR患者高34%(调整后HR = 1.34; 95% CI: 1.20-1.51; P < 0.0001)。较高的HbA1c水平也与死亡率增加相关(每增加1%:HR = 1.07; 95% CI: 1.04-1.10; P < 0.0001), HbA1c水平最高的参与者的死亡风险比最低水平的参与者高30% (HR:1.30; 95% CI: 1.14-1.48; P < 0.0001)。中介分析表明,HbA1c占与DR相关的额外死亡风险的9.1%,表明DR可能部分通过增加血糖负担来提高死亡风险。结论:sdr与全因死亡风险增加有关,而这种额外的风险似乎与较高的HbA1c水平部分相关。这些发现表明,血糖负荷升高可能是糖尿病成人患者DR与死亡率增加之间的一个途径。
Diabetic retinopathy and mortality in adults with diabetes: causal mediation analysis of the role of HbA1c
Background
Diabetic retinopathy (DR) is a well-established risk factor for increased mortality in diabetes, but the mechanisms remain unclear. Chronic hyperglycemia, reflected by glycated hemoglobin (HbA1c), may be one pathway linking DR to adverse outcomes, yet its mediating role is not well defined.
Methods
We analyzed data from 5658 adults with self-reported diabetes in the NHANES 2001–2018 cycles. DR was assessed via questionnaire, HbA1c was measured using standardized laboratory methods, and all-cause mortality was determined through linkage to the National Death Index. Cox proportional hazards models were used to assess the association between HbA1c and mortality. Causal mediation analysis was conducted using the mediation R package.
Results
Participants with DR had a 34 % higher risk of all-cause mortality compared with those without DR (adjusted HR = 1.34; 95 % CI: 1.20–1.51; P < 0.0001). Higher HbA1c levels were also associated with increased mortality (per 1 % increase: HR = 1.07; 95 % CI: 1.04–1.10; P < 0.0001), and participants in the highest HbA1c tertile had a 30 % greater risk of death than those in the lowest tertile (HR:1.30; 95 %CI:1.14–1.48; P < 0.0001). Mediation analysis indicated that HbA1c accounted for 9.1 % of the excess mortality risk associated with DR, suggesting that DR may elevate mortality risk partly through increased glycemic burden.
Conclusions
DR is associated with an increased risk of all-cause mortality, and this excess risk appears to be partly linked through higher HbA1c levels. These findings suggest that elevated glycemic burden may serve as one pathway connecting DR to increased mortality in adults with diabetes.
期刊介绍:
Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.